Targeting pain and inflammation arising from a wide range of medical conditions
MORE
Leveraging our proprietary hydrogen sulfide platform to develop next-generation therapies for pain and inflammation arising from a wide range of medical conditions.
“I’m excited to employ my neuroscience background in the development of novel non-addictive analgesics – we have an opportunity to make a big difference!”
Svetlana Kurklinsky, PhD, Director of Clinical Science, Antibe Therapeutics